206 related articles for article (PubMed ID: 31436152)
1. Utility of PCR in Patients with
Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M
Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152
[No Abstract] [Full Text] [Related]
2. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
4. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
5. Real-time PCR for detection of Strongyloides stercoralis in human stool samples from Côte d'Ivoire: diagnostic accuracy, inter-laboratory comparison and patterns of hookworm co-infection.
Becker SL; Piraisoody N; Kramme S; Marti H; Silué KD; Panning M; Nickel B; Kern WV; Herrmann M; Hatz CF; N'Goran EK; Utzinger J; von Müller L
Acta Trop; 2015 Oct; 150():210-7. PubMed ID: 26215130
[TBL] [Abstract][Full Text] [Related]
6. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
7. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
8. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
10. Strongyloides stercoralis: a rare and severe presentation in a pregnant woman.
Beltrán Rosel A; Sanjoaquín Conde I; Pérez Muñoz A; Alcalá PM; Marta CB; Irigoyen von Sierakowski A
New Microbiol; 2020 Jan; 43(1):44-46. PubMed ID: 31814031
[TBL] [Abstract][Full Text] [Related]
11. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M
Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of Opisthorchis viverrini and Strongyloides stercoralis in human fecal samples using a duplex real-time PCR and melting curve analysis.
Janwan P; Intapan PM; Thanchomnang T; Lulitanond V; Anamnart W; Maleewong W
Parasitol Res; 2011 Dec; 109(6):1593-601. PubMed ID: 21537984
[TBL] [Abstract][Full Text] [Related]
13. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
Robinson RD; Lindo JF; Neva FA; Gam AA; Vogel P; Terry SI; Cooper ES
J Infect Dis; 1994 Mar; 169(3):692-6. PubMed ID: 8158055
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of strongyloidiasis among patients with HTLV-1/2 seen at the outpatient clinic of the Núcleo de Medicina Tropical, Belém, State of Pará, Brazil.
Furtado KC; Costa CA; Ferreira Lde S; Martins LC; Linhares Ada C; Ishikawa EA; Batista Ede J; Sousa MS
Rev Soc Bras Med Trop; 2013; 46(2):241-3. PubMed ID: 23740053
[TBL] [Abstract][Full Text] [Related]
15. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
Gillet NA; Cook L; Laydon DJ; Hlela C; Verdonck K; Alvarez C; Gotuzzo E; Clark D; Farré L; Bittencourt A; Asquith B; Taylor GP; Bangham CR
PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987
[TBL] [Abstract][Full Text] [Related]
16. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru.
Gotuzzo E; Terashima A; Alvarez H; Tello R; Infante R; Watts DM; Freedman DO
Am J Trop Med Hyg; 1999 Jan; 60(1):146-9. PubMed ID: 9988339
[TBL] [Abstract][Full Text] [Related]
17. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
[TBL] [Abstract][Full Text] [Related]
18. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y
Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366
[TBL] [Abstract][Full Text] [Related]
19. Duodenal obstruction due to
Harshan M; Niyas VKM; Arjun R
Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224
[No Abstract] [Full Text] [Related]
20. Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth.
Springer LE; Patton JB; Zhan T; Rabson AB; Lin HC; Manser T; Lok JB; Hess JA; Abraham D
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009559. PubMed ID: 34314415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
